Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor

British Journal of Cancer

Volumn 73, Issue 11, 1996, Pages 1366-1372

  Okamoto, S ^a,b   Yoshikawa, K ^a,c   Obata, Y ^a   Shibuya, M ^d   Aoki, S ^c   Yoshida, J ^b   Takahashi, T ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Epidermal growth factor receptor; Glioblastoma; Internal deletion; Monoclonal antibody

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN G2B; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DELETION MUTANT; FEMALE; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029949509     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.260     Document Type: Article

References (30)

1. BABA E, NAKAMURA M, OHKUMA K, KIRA J, TANAKA Y, NAKANO S AND NIHO Y. (1995). A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies. J. Immunol., 154, 399-412.
2. BERGERHEIM U, NORDENSKJOLD M AND COLLIS VP. (1989). Deletion mapping in human renal cell carcinoma. Cancer Res., 49, 1390-1396.
3. BIGNER SH, HUMPHREY PA, WONG AJ, VOGELSTEIN B, MARK J, FRIEDMAN HS AND BIGNER DD. (1990). Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res., 50, 8017-8022.
4. CAREY TE, TAKAHASHI T, RESNICK LA, OETTGEN HG AND OLD LJ. (1976). Cell surface antigens of human malignant melanoma: mixed hemadsorption assay for humoral immunity to cultured autologous melanoma cells. Proc. Natl Acad. Sci. USA, 73, 3278-3282.
5. CARPENTER G. (1987). Receptors for epidermal growth factor and other polypeptide mitogens. Annu. Rev. Biochem., 56, 881-914.
6. EKSTRAND AJ, SUGAWA N, JAMES CD AND COLLINS VP. (1992). Amplified and rearranged epidermal growth factor receptor gene in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc. Natl Acad. Sci. USA, 89, 4309-4313.
7. FAGRAEUS A, ESPMARK JA AND JONSSON J. (1965). Mixed haemadsorption: a mixed antiglobulin reaction applied to antigens on a glass surface. Preparation and evaluation of indicator red cells: survey of present applications. J. Immunol., 9, 161-175.
8. GARCIA DE PALAZZO IE, ADAMS GP, SUNDARESHAN P, WONG AJ, TESTA JR, BIGNER DD AND WEINER LM. (1993). Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res., 53, 3217-3220.
9. HUMPHREY PA, WONG AJ, VOGELSTEIN B, FRIEDMAN HS, WERNER MH, BIGNER DD AND BIGNER SH. (1988). Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res., 48, 2213-2238.
10. HUMPHREY PA, WONG AJ, VOGELSTEIN B, ZALUTSKY MR, FULLER GN, ARCHER GE, FRIEDMAN HS, KWATRA MM, BIGNER SH AND BIGNER DD. (1990). Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc. Natl Acad. Sci. USA, 87, 4207-4211.
11. HUMPHREY PA, GANGAROSA LM, WONG AJ, ARCHER GE, LUNDJOHANSEN ML, BJERKVIG R, LAERUM O-D, FRIEDMAN HS AND BIGNER DD. (1991). Deletion-mutant epidermal growth factor receptor in human gliomas: effect of type II mutation on receptor function. Biochem. Biophys. Res. Commun., 178, 1413-1420.
12. JAMES CD, CARLBOM E, DUMANSKI JP, HANSEN M, NORDENSKJOLD M, COLLIS VP AND CAVENEE WK. (1988). Clonal genomic alterations in glioma malignancy stages. Cancer Res., 48, 5546-5551.
13. KIKUCHI T, TAKAHASHI M, UEDA R, OHBA M, SEITO T, HIAI H, NAKASHIMA I AND TAKAHASHI T. (1990). Nuclear localization of antigens detected by a monoclonal antibody against a synthetic peptide of rfp finger protein. Hybridoma, 9, 189-200.
14. LIBERMANN TA, RAZON N, BARTAL AD, YARDEN Y, SCHLESSINGER J AND SCOREQ H. (1984). Expression of epidermal growth factor receptors in human brain tumors. Cancer Res., 44, 753-760.
15. NIELSEN B, BORUP-CHRISTENSEN P, ERB K, JENSENIUS JC AND HUSBY S. (1987). A method for the blocking of endogenous immunoglobulin on frozen sections in the screening of human hybridoma antibody in culture supernatants. Hybridoma, 6, 103-109.
16. PALKER TJ, MATTHEWS TJ, LANGLOIS A, TANNER ME, MARTIN ME, SCEARCE RM, KIM JE, BERZOFSKY JA, BOLOGNESI DP AND HAYNES BF. (1989). Polyvalent human immunodeficiency virus synthetic immunogen composed of envelope gp120 T helper cell sites and B cell neutralization epitopes. J. Immunol., 142, 2024-2029.
17. RAMMENSEE H-G, FRIEDE T AND STEVANOVIC TFS. ( 1995). MHC ligands and peptide motifs: first listing. Immunogenetics, 41, 178-228.
18. SETO M, TAKAHASHI T, TANIMOTO M AND NISHIZUKA Y. (1982). Production of monoclonal antibodies against MM antigen: the serologic identification of MM antigen with LY-6.2 alloantigen. J. Immunol., 128, 201-205.
19. SUGAWA N, EKSTRAND AJ, JAMES CD AND COLLINS VP. (1990). Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc. Natl Acad. Sci. USA, 87, 8602-8606.
20. UEDA R, NISHIDA K, KOIDE Y, TSUGE I, SETO M, YOSHIDA M, MIYOSHI I, OTA K AND TAKAHASHI T. (1985). Two mouse monoclonal antibodies detecting two different epitopes of an activated lymphocyte antigen on adult T-cell leukemia cells. Cancer Res., 45, 1314-1319.
21. ULLRICH A, COUSSENS L, HAYFLICK JS, DULL TJ, GRAY A, TAM AW, LEE J, YARDEN Y, LIBERMANN TA AND SCHLESSINGER J. (1984). Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermal carcinoma cells. Nature, 309, 418-425.
22. WATERFIELD MD, MAYERS ELV, STROOBAND P, BENNET PLP, YOUNG S, GOODFELLOW PN, BANTING GS AND OZANNE B. (1982). A monoclonal antibody to the human epidermal growth factor receptor. J. Cell. Biochem., 20, 149-161.
23. WIKSTRAND CJ, STANLEY SD, HUMPHREY PA, PEGRAM CN, ARCHER GE, KURPAD S, SHIBUYA M AND BIGNER DD. (1993). Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomas. J. Neuroimmunol., 46, 165-174.
24. WIKSTRAND CJ, HALE LP, BATRA SK, HILL ML, HUMPHREY PA, KURPAD SN, MCLENDON RE, MOSCATELLO D, PEGRAM CN, REIST CJ, TRAWEELE ST, WONG AJ, ZALUTSKY MR AND BIGNER DD. (1995). Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res., 55, 3140-3148.
25. WONG AJ, BIGNER SH, BIGNER DD, KINZLER KW, HAMILTON SR AND VOGELSTEIN B. (1987). Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl Acad. Sci. USA, 84, 6899-6903.
26. WONG AJ, RUPPERT JM, BIGNER SH, GRZESCHIK KH, HUMPHREY PA, BIGNER DD AND VOGELSTEIN B. (1992). Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl Acad. Sci. USA, 89, 2965-2969.
27. YAMAZAKI H, FUKUI Y, UEYAMA Y, TAMAOKI N, KAWAMOTO T, TANIGUCHI S AND SHIBUYA M. (1988). Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol. Cell Biol., 8, 1816-1820.
28. YAMAZAKI H, OHBA Y, TAMAOKI N AND SHIBUYA M. (1990). A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors. Jpn. J. Cancer Res., 81, 773-779.
29. YOSHIKAWA K, UEDA R, OBATA Y, UTSUMI KR, NOTAKE K AND TAKAHASHI T. (1986). Human monoclonal antibody reactive to stomach cancer produced by mouse- human hybridoma technique. Jpn. J. Cancer Res., 77, 1122-1133.
30. YOSHIKAWA K, FURUKAWA K, UEDA R, IWASA S, LLOYD KO, NOTAKE K AND TAKAHASHI T. (1989). A human monoclonal antibody recognizing a surface antigen on stomach cancer cells. Jpn. J. Cancer Res., 80, 546-553.